Clinical Trial Update: PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating SC-DARIC33 CAR T cells in pediatric and young adult patients with relapsed or refractory CD33-positive acute myeloid leukemia; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• SC-DARIC33 CAR T cells

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory | Phase 1 | Status: RECRUITING